| Acquirer | Target | Price |
|---|---|---|
| EQT Partners | Press Ganey | $2.35 billion |
| Carter Validus Mission Critical REIT II | HPI portfolio | $116.5 million |
| Allergan plc | ForSight VISIONS | $95 million |
| Scintilla Pharmaceuticals | SCILEX Pharmaceuticals | $70 million |
| ZymeWorks Inc. | License to HuTARG platform | $65 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
